外科理论与实践 ›› 2023, Vol. 28 ›› Issue (03): 186-189.doi: 10.16139/j.1007-9610.2023.03.002
收稿日期:
2023-04-26
出版日期:
2023-05-25
发布日期:
2023-08-18
通讯作者:
张忠涛,E-mail: YANG Yingchi, PANG Kai, ZHANG Zhongtao()
Received:
2023-04-26
Online:
2023-05-25
Published:
2023-08-18
摘要:
对于中、低位进展期直肠癌,目前的国内、外指南均推荐先行新辅助放、化疗或全程新辅助治疗后再行根治性手术。近年来,免疫检查点抑制剂对于相应敏感的微卫星高度不稳定/错配修复缺陷直肠肿瘤病人的显著疗效已得到公认。最新的研究报道显示,在微卫星稳定/错配修复正常的直肠癌新辅助治疗中,将免疫检查点抑制剂与放疗结合,亦可获得显著的肿瘤退缩,有望开启直肠癌新辅助治疗的全新时代。即便如此,手术仍是当前直肠癌多学科诊疗模式中的中心环节。但可以预见的是,更为显著的术前肿瘤退缩将会极大地促进直肠癌微创术式的广泛开展。以经肛门内镜显微手术、经肛全直肠系膜切除术、腹腔镜全直肠系膜切除术+经自然腔道标本取出手术为代表的直肠癌微创术式有望得到进一步推广,成为直肠癌放疗联合免疫治疗时代的标准术式。
中图分类号:
杨盈赤, 庞凯, 张忠涛. 新辅助放疗联合免疫治疗对直肠癌微创术式应用的影响[J]. 外科理论与实践, 2023, 28(03): 186-189.
YANG Yingchi, PANG Kai, ZHANG Zhongtao. Influence of neoadjuvant radiotherapy combined with immunotherapy on minimally invasive surgeries for rectal cancer[J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 186-189.
[1] |
SHI J F, WANG L, RAN J C, et al. Clinical characteristics, medical service utilization, and expenditure for colorectal cancer in China, 2005 to 2014: overall design and results from a multicenter retrospective epidemiologic survey[J]. Cancer, 2021, 127(11):1880-1893.
doi: 10.1002/cncr.v127.11 URL |
[2] |
SAUER R, BECKER H, HOHENBERGER W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer[J]. N Engl J Med, 2004, 351(17):1731-1740.
doi: 10.1056/NEJMoa040694 URL |
[3] |
YAMAUCHI M, LOCHHEAD P, MORIKAWA T, et al. Colorectal cancer: a tale of two sides or a continuum?[J]. Gut, 2012, 61(6):794-797.
doi: 10.1136/gutjnl-2012-302014 URL |
[4] |
LIN Z, CAI M, ZHANG P, et al. Phase Ⅱ, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer[J]. J Immunother Cancer, 2021, 9(11):e003554.
doi: 10.1136/jitc-2021-003554 URL |
[5] |
SHAMSEDDINE A, ZEIDAN Y H, E L HUSSEINI Z, et al. Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma[J]. Radiat Oncol, 2020, 15(1):233.
doi: 10.1186/s13014-020-01673-6 |
[6] |
SALVATORE L, BENSI M, CORALLO S, et al. Phase Ⅱ study of preoperative (PREOP) chemoradiotherapy (CTRT) plus avelumab (AVE) in patients (PTS) with locally advanced rectal cancer (LARC): the AVANA study[J]. J Clin Oncol, 2021, 39(15_suppl):3511-3511.
doi: 10.1200/JCO.2021.39.15_suppl.3511 URL |
[7] |
BANDO H, TSUKADA Y, INAMORI K, et al. Preoperative chemoradiotherapy plus nivolumab before surgery in patients with microsatellite stable and microsatellite instability-high locally advanced rectal cancer[J]. Clin Cancer Res, 2022, 28(6):1136-1146.
doi: 10.1158/1078-0432.CCR-21-3213 URL |
[8] |
Yang Z, Zhang X, Zhang J, et al. Safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer: short-term results of a multicenter, phase Ⅱ study[J]. J Clin Oncol, 2022, 40(16):e15599-e15599.
doi: 10.1200/JCO.2022.40.16_suppl.e15599 URL |
[9] | BUESS G, THEISS R, HUTTERER F, et al. Transanal endoscopic surgery of the rectum - testing a new method in animal experiments[J]. Leber Magen Darm, 1983, 13(2):73-77. |
[10] | HEROLD A, LEHUR P-A, MATZEL KE, et al. Coloproctology[M]. 2nd ed. Springer, 2017. |
[11] |
KIDANE B, CHADI S A, KANTERS S, et al. Local resection compared with radical resection in the treatment of T1N0M0 rectal adenocarcinoma: a systematic review and meta-analysis[J]. Dis Colon Rectum, 2015, 58(1):122-140.
doi: 10.1097/DCR.0000000000000293 URL |
[12] |
RULLIER E, ROUANET P, TUECH J J, et al. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial[J]. Lancet, 2017, 390(10093):469-479.
doi: 10.1016/S0140-6736(17)31056-5 URL |
[13] |
SYLLA P, RATTNER D W, DELGADO S, et al. Notes transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance[J]. Surg Endosc, 2010, 24(5):1205-1210.
doi: 10.1007/s00464-010-0965-6 URL |
[14] |
ADAMINA M, BUCHS N C, PENNA M, et al. Gallen Colorectal Consensus Expert Group. St. Gallen consensus on safe implementation of transanal total mesorectal excision[J]. Surg Endosc, 2018, 32(3):1091-1103.
doi: 10.1007/s00464-017-5990-2 URL |
[15] |
ZHANG X, GAO Y, DAI X, et al. Short- and long-term outcomes of transanal versus laparoscopic total mesorectal excision for mid-to-low rectal cancer: a meta-analysis[J]. Surg Endosc, 2019, 33(3):972-985.
doi: 10.1007/s00464-018-6527-z |
[16] |
WASMUTH H H, FAERDEN A E, MYKLEBUST T Å, et al. Transanal total mesorectal excision for rectal cancer has been suspended in Norway[J]. Br J Surg, 2020, 107(1):121-130.
doi: 10.1002/bjs.11459 URL |
[17] | 中国NOSES联盟, 中国医师协会结直肠肿瘤专业委员会 NOSES专委会. 结直肠肿瘤经自然腔道取标本手术专家共识( 2019版)[J]. 中华结直肠疾病电子杂志, 2019, 8(4):336-342. |
China NOSES Alliance, Professional Committee of Natural Orifice Specimen Extraction Surgery, Colorectal Cancer Committee of Chinese Medical Doctor Association. Expert consensus of natural orifice specimen extraction surgery in colorectal neoplasm (2019)[J]. Chin J Colorectal Dis(Electronic Edition), 2019, 8(4):336-342. | |
[18] |
IP H Y, ABRISHAMI A, PENG P W, et al. Predictors of postoperative pain and analgesic consumption: a qualitative systematic review[J]. Anesthesiology, 111(3):657-677.
doi: 10.1097/ALN.0b013e3181aae87a URL |
[1] | 骆洋, 钟鸣. 腹腔镜低位直肠癌前切除术吻合口漏的预防和治疗[J]. 外科理论与实践, 2023, 28(03): 220-225. |
[2] | 骆洋, 俞旻皓, 叶光耀, 林海萍, 贡婷月, 李浩, 钟鸣. 术中吲哚菁绿荧光显像评估在降低腹腔镜直肠癌术后吻合口漏的应用价值[J]. 外科理论与实践, 2023, 28(03): 249-253. |
[3] | 韩序, 王文权, 楼文晖, 刘亮. 免疫检查点抑制剂治疗胃肠胰神经内分泌肿瘤的进展[J]. 外科理论与实践, 2023, 28(03): 267-272. |
[4] | 邢颖, 程石. 胆囊癌新辅助治疗的现状和争议[J]. 外科理论与实践, 2023, 28(02): 110-114. |
[5] | 潘林锋, 徐玺谟, 巴突尔·艾克木, 邓漾, 张森, 秦伟, 殳舵获, 蔡正昊, 宋海勤, 杨晓, 钟昊, 胡延岩, 李健文, 冯波. 经肛全直肠系膜切除术用于直肠癌吻合口复发的再手术[J]. 外科理论与实践, 2023, 28(02): 132-138. |
[6] | 王远江, 邹浩. 胆囊癌综合治疗的临床研究[J]. 外科理论与实践, 2023, 28(02): 171-176. |
[7] | 李建芳, 余俊贤, 严超, 朱正纲, 刘炳亚. 胃癌基础与转化研究的热点问题[J]. 外科理论与实践, 2023, 28(01): 7-16. |
[8] | 胡磊, 许亚龙, 刘少军, 何义仁, 刘流, 朱志强. 简易支撑架联合一针缝合法在直肠癌末端回肠造口中的应用[J]. 外科理论与实践, 2023, 28(01): 77-82. |
[9] | 张天羽, 周东, 洪桢. 《儿童抗NMDAR脑炎治疗的国际共识推荐》解读[J]. 诊断学理论与实践, 2022, 21(06): 677-683. |
[10] | 李佳曦, 汪锦江, 俞立萍, 袁英, 乔光磊, 马俐君. RAB25沉默抑制结直肠癌细胞铁死亡的作用研究[J]. 诊断学理论与实践, 2022, 21(06): 710-718. |
[11] | 何燕燕, 李凤珠. 膀胱原发性上皮样血管肉瘤一例报道及文献复习[J]. 诊断学理论与实践, 2022, 21(06): 719-725. |
[12] | 任佳逸, 糜坚青. 新型抗体类药物在急性B淋巴细胞白血病中的治疗进展[J]. 内科理论与实践, 2022, 17(06): 463-467. |
[13] | 殷剑光, 宗雅萍, 沈晓卉, 赵敬坤, 陆爱国. 同时性多原发结肠直肠癌治疗与预后分析(附39例报告)[J]. 外科理论与实践, 2022, 27(06): 540-544. |
[14] | 马丽英, 孙隆慈, 张斌, 吴志勇. 腹会阴联合切除术后腹膜内与腹膜外造口的比较和研究[J]. 外科理论与实践, 2022, 27(06): 555-557. |
[15] | 郭子超, 程兮, 张弢, 赵任. 经肛全直肠系膜切除临床应用的现状及展望[J]. 外科理论与实践, 2022, 27(06): 558-562. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||